VHL
About
Location: 3p25.3
Mappings
Biomarkers
VHL is involved in the following curated biomarkers.
| Name | Biomarker type | Propositions | Statements |
|---|---|---|---|
| VHL pathogenic variants | Germline variant | 3 | 3 |
Therapeutic response
Precision oncology relationships for therapeutic response involving this gene.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | VHL pathogenic variants | Renal Cell Carcinoma | Belzutifan | |
| FDA (1) | VHL pathogenic variants | Central Nervous System Hemangioblastoma | Belzutifan | |
| FDA (1) | VHL pathogenic variants | Pancreatic Neuroendocrine Tumor | Belzutifan |